Tadalafil Gains Attention as Potential Longevity Aid Amid Off-Label Push

Tadalafil, sold under the brand name Cialis for erectile dysfunction, is now being advertised by online clinics and prominent wellness figures as a general longevity medication. While the drug is approved for erectile dysfunction, pulmonary hypertension, and benign prostatic hyperplasia, several large observational studies have found men on tadalafil experience lower rates of cardiovascular death, overall mortality, and dementia.

Researchers such as Robert Kloner and Dietrich Jehle describe the pattern as a consistent signal but stress that without prospective randomized trials the findings remain associative. Some clinicians, including Martin Miner, have begun prescribing low-dose tadalafil to men at high cardiovascular risk, though formal guidelines are pending. Critics like Steve Nissen caution that the absence of controlled data does not guarantee safety, especially for women, who are less studied. Companies like AgelessRx now sell monthly low-dose prescriptions, reflecting a growing market despite regulatory uncertainty.